Research progress on novel bionic cryoprotectants in gamete and embryo cryopreservation
Yang L., Yang Z., Guo X., Zheng Y., Li S., Du W.
Narrative Review, published in Front Vet Sci (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Front Vet Sci (2026)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 42078852
- PMCID
- PMC13130884
- DOI
- 10.3389/fvets.2026.1797831
Abstract (original English)
Cryopreservation technology has become a primary method for preserving animal genetic resources in the biomedical field. It achieves long-term storage by placing gametes or embryos in an ultra-low-temperature environment, enabling them to retain biological activity after thawing. However, the cytotoxicity issues associated with traditional cryoprotectants limit their application, making the development of non-toxic and highly effective novel cryoprotectants a current research priority. This review systematically reviews the development history and principles of cryopreservation technology, and summarizes the classification and mechanisms of action of cryoprotectants, with a particular focus on five types of novel cryoprotectants featuring bioinspired structural characteristics. Their ice-suppression performance and mechanisms of action are analyzed. These protectants possess structures similar to those of natural antifreeze substances and exhibit low toxicity, thereby demonstrating higher cryopreservation efficiency, and are thus referred to as novel bioinspired cryoprotectants. Furthermore, this review examines the potential applications of the aforementioned protectants in the cryopreservation of animal gametes (sperm, oocytes, and embryos), offering new insights into expanding the use of bioinspired cryoprotectants in the preservation of animal genetic resources.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.